Resultado de búsqueda
Steverink N, Slaets JPJ, Schuurmans H, van Lis M. Measuring frailty: Development and testing of the Groningen Frailty Indicator (GFI). Gerontologist. 2001;41 (special issue 1):236–237.
GFI seems an useful screening tool in cancer patients older than 70 years who are considered suitable by their oncologists to receive chemotherapy GFI and MNA predict survival in elderly cancer patients who are consid didered to be fit for chemotherapy
The Groningen Frailty Indicator (GFI) has been developed to identify frailty. We assessed feasibility, reliability, and construct validity of the self-assessment version of the GFI. Design: Cross-sectional. Setting: Community-based.
21 de may. de 2013 · Alternatively, another approach to measure frailty in the primary care setting is with a self-assessment questionnaire, such as the 15-item Groningen Frailty Indicator (GFI). The GFI questionnaire screens for self-reported limitations and is widely used in The Netherlands .
Each of the current frailty screening tools are used in different clinical situations, and therefore, the clinical practice applications of these frailty screening tools are summarized graphically to provide the most intuitive screening and reference for clinical practitioners.
1 de ene. de 2001 · The Groningen Frailty Indicator (GFI) is a 15-item selfreported screening tool that includes four domains of frailty: physical components (mobility, comorbidity, physical energy, vision,...
Background: The primary objective of the present study was to evaluate the validity of the Groningen Frailty Indicator (GFI) in a sample of Dutch elderly persons participating in LifeLines, a large population-based cohort study.
